USPTO serial 97184483
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $300
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bryan W. Bockhop
Bryan W. Bockhop BOCKHOP INTELLECTUAL PROPERTY LAW, LLC2375 MOSSY BRANCH DRIVESNELLVILLE, GA 30078United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical implants comprising living tissues; pharmaceutical preparations, namely, haemostatic agents, blood clotting agents, and blood clotting powder for use in improving blood coagulation and supporting natural blood cascade; adhesive bandages with blood clotting properties; pharmaceutical preparations for the treatment of infectious diseases; haemostatic agents in the nature of medical and dental haemostatic powder for medical purposes; chemical hemostatic preparations, namely, blood clotting agents for use in improving blood coagulation and supporting natural blood cascade; chemical hemostatic preparations, namely, blood clotting powder for use in improving blood coagulation and supporting natural blood cascade; haemostatic agents, namely, haemostatic powders in the nature of medical and dental haemostatic powder for medical purposes | ACTIVE | — |
| 010 | Surgical instruments and apparatus; medical instruments and apparatus for treating all kinds of bleedings; dental instruments and apparatus for treating all kind of dental bleedings; orthopedic device for treating bleeding during orthopedic procedures; medical devices for closing wounds, namely, surgical stitches; blood clotting surgical sponge; surgical implants comprising artificial material with a blood clotting coating; blood clotting coated surgical implants from artificial materials | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 8, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 7, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 24, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 24, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 25, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 24, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 24, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 24, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 17, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 17, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 16, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 24, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 24, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 24, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 25, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 24, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 24, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 24, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 24, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 29, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 26, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 26, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 26, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 28, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 25, 2021 | NWAP | NEW APPLICATION ENTERED | — |